We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma community.
Explore this page to learn about the latest blood cancer research from 2019 American Society of Hematology annual meeting, especially key clinical trials to advance the treatment and management of multiple myeloma.
When you select the International Myeloma Foundation as your preferred charity from AmazonSmile, Amazon gives to the IMF—at no added cost to you!
Details about co-pay assistance programs for multiple myeloma patients.
As we head into 2020, it’s important to be realistic about what individuals can and cannot do about large-scale challenges, like climate change. In his blog this week, Dr. Brian G.M. Durie shares lots of helpful guidance about the healthiest way to move forward in the new yea—without “freaking out” about the problems we cannot solve on our own. Try eating less meat, more beans, take walks, and have clear plans in place to manage your myeloma.
In this week’s video, Dr. Durie discusses how the acquisition of Celgene Corporation by Bristol-Myers Squibb will impact the lives of myeloma patients.
Need to stay informed about the news that impacts myeloma patients, but don’t have time to read everything out there? Then be sure to follow Dr. Brian Durie’s Week in Review blog. The leading myeloma expert and IMF Chairman of the Board drills down on a wide range of topics – from the latest myeloma research results to the environmental issues that offer insight into prevention. He sifts through the data to deliver the bottom line.
The support of loved ones allows us to continue to fund efforts to search for a cure. Check out how Fundraisers are helping in the fight against myeloma.
